No Recent News for the Company
Announcement under Regulation 30 (LODR)-Press Release / Media Release
02-Feb-2026 | Source : BSELupin Launches Dasatinib Tablets in the United States.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
02-Feb-2026 | Source : BSELupin and TB Alliance Join Forces to Advance Telacebec for the Treatment of Tuberculosis and Other Mycobacterial Diseases.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
28-Jan-2026 | Source : BSESchedule of Earnings Call for Unaudited Financial Results of Q3 FY26.
Corporate Actions
No Upcoming Board Meetings
Lupin Ltd. has declared 600% dividend, ex-date: 25 Jul 25
Lupin Ltd. has announced 2:10 stock split, ex-date: 27 Aug 10
Lupin Ltd. has announced 1:1 bonus issue, ex-date: 11 Aug 06
No Rights history available